
About Avansdose
Avansdose is a Healthcare company based in Ankleshwar (India) founded in 2020. It manufactures and supplies oncology APIs with RD and quality control standards. It operates on a B2B model. Its Indian entity Avansdose Pharmatech Private Limited reported revenue of βΉ12.71 Cr. Avansdose offers products and services including Oncology API and Synthesis Peptides. Its focus areas include Healthcare and Pharmaceuticals, API Manufacturing, Oncology and API Production. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
AvansDose specializes in manufacturing high-quality oncology APIs, emphasizing cost-effectiveness and adherence to Good Manufacturing Practices. They operate RD facilities focused on oncology products and expanding to peptides. Located in Hyderabad, India, they ensure compliance with environmental and safety regulations while supplying APIs for life-saving drugs to global clients.
- Headquarters Ankleshwar, India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website avansdose.com
- Legal Name Avansdose Pharmatech Private Limited
- Date of Incorporation 27 Feb, 2017
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹12.71 Cr
FY 2025 · -26% YoY
- Net Loss-₹49.4 Lakh
FY 2025 · -4% margin
- EBITDA-₹43.5 Lakh
FY 2025 · -3% margin
Associated legal entities of Avansdose
Avansdose operates through Avansdose Pharmatech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Avansdose Pharmatech Private Limited CIN U74999TG2017PTC115497 | Active | 27 Feb 2017 | Hyderabad, Telangana | ₹12.7 Cr | 2 | View details |
Products & Services of Avansdose
Avansdose offers a comprehensive portfolio of products and services, including Oncology API and Synthesis Peptides.
Produces high-quality APIs for oncology drugs and treatments.
Develops peptides for various therapeutic categories.
Board of directors of Avansdose Pharmatech Private Limited (Avansdose)
Avansdose Pharmatech Private Limited is the primary company behind Avansdose. The board of Avansdose Pharmatech Private Limited currently have 2 directors; the longest-serving is Ravindra Balwani, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ravindra Balwani DIN 02115242 | Director | 27 Feb 2017 | 9 yrs 8 mo | Avansdose Pharmatech Private Limited |
| Gagan Jot Singh DIN 05271026 | Director | 27 Feb 2017 | 9 yrs 8 mo | Avansdose Pharmatech Private Limited |
Financials of Avansdose
Figures of Avansdose Pharmatech Private Limited, the primary company behind Avansdose, for FY 2025. Revenue was ₹12.71 Cr (-26% year on year). Net loss was -₹49.4 Lakh (-4% margin). EBITDA was -₹43.5 Lakh (-3% margin). Revenue has grown at a compounded annual rate of +6% over three years and +186% over five years.
- ₹12.71 CrRevenue · FY 2025 · -26% YoY
- -₹49.4 LakhNet loss · -4% margin
- -₹43.5 LakhEBITDA · -3% margin
- ₹10,000Paid-up capital
- +6%Revenue CAGR, 3 years
- +186%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Avansdose Pharmatech Private Limited are on its company page.
Detailed financial statements for Avansdose
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Avansdose
Avansdose has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Avansdose
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Avansdose
Avansdose was founded in 2020.
Avansdose is headquartered in Ankleshwar, India. It is registered at Ankleshwar, Gujarat, India.
The primary company behind Avansdose, Avansdose Pharmatech Private Limited, reported revenue of βΉ12.71 Cr for FY 2025, down 26% year on year.
AvansDose specializes in manufacturing high-quality oncology APIs, emphasizing cost-effectiveness and adherence to Good Manufacturing Practices. They operate RD facilities focused on oncology products and expanding to peptides. Located in Hyderabad, India, they ensure compliance with environmental and safety regulations while supplying APIs for life-saving drugs to global clients.
Avansdose's top competitors include Laurus Labs, Symbiotec and SeQuent.
Avansdose offers Oncology API and Synthesis Peptides.
Avansdose operates through Avansdose Pharmatech Private Limited.
The legal entities of Avansdose currently have 2 directors, including Ravindra Balwani, Gagan Jot Singh.